Combination of tanshinone IIA and doxorubicin possesses synergism and attenuation effects on doxorubicin in the treatment of breast cancer

MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer

(2018) Manxin Xie et al.   BIOMEDICINE & PHARMACOTHERAPY

The challenge of drug resistance in cancer treatment: a current overview

(2018) Michail Nikolaou et al.   CLINICAL & EXPERIMENTAL METASTASIS

Quercetin reversed MDR in breast cancer cells through down-regulating P-gp expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation

(2018) Shizheng Li et al.   PHYTOTHERAPY RESEARCH

Cytotoxicity of Tanshinone IIA combined with Taxol on drug-resist breast cancer cells MCF-7 through inhibition of Tau

(2018) Hui Lin et al.   PHYTOTHERAPY RESEARCH

Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer

(2018) Pedro Veronese et al.   PLoS One

MiR-222 promotes drug-resistance of breast cancer cells to adriamycin via modulation of PTEN/Akt/FOXO1 pathway

(2017) Hongyu Shen et al.   GENE

Functional screen analysis reveals miR-3142 as central regulator in chemoresistance and proliferation through activation of the PTEN-AKT pathway in CML

(2017) Lifen Zhao et al.   Cell Death & Disease

Quercetin Increase the Chemosensitivity of Breast Cancer Cells to Doxorubicin Via PTEN/Akt Pathway

(2015) Shi-zheng Li et al.   Anti-Cancer Agents in Medicinal Chemistry

Structure, mechanism and cooperation of bacterial multidrug transporters

(2015) Dijun Du et al.   CURRENT OPINION IN STRUCTURAL BIOLOGY

Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor

(2015) Yanzuo Chen et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Development, Maintenance, and Reversal of Multiple Drug Resistance: At the Crossroads of TFPI1, ABC Transporters, and HIF1

(2015) Terra Arnason et al.   Cancers

Pharmacological postconditioning with tanshinone IIA attenuates myocardial ischemia-reperfusion injury in rats by activating the phosphatidylinositol 3-kinase pathway

(2014) XUN YUAN et al.   Experimental and Therapeutic Medicine

Mechanisms of Drug Resistance in Cancer Chemotherapy: Coordinated Role and Regulation of Efflux Transporters and Metabolizing Enzymes

(2013) Ramya Vadlapatla et al.   CURRENT PHARMACEUTICAL DESIGN

UDP-Glucuronosyltransferase 1A Compromises Intracellular Accumulation and Anti-Cancer Effect of Tanshinone IIA in Human Colon Cancer Cells

(2013) Miao Liu et al.   PLoS One

Tanshinone IIA Induces Mitochondria Dependent Apoptosis in Prostate Cancer Cells in Association with an Inhibition of Phosphoinositide 3-Kinase/AKT Pathway

(2010) Suk-Hyun Won et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

First-line chemotherapy with or without biologic agents for metastatic breast cancer

(2010) Claudia Andreetta et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Doxorubicin pathways

(2010) Caroline F. Thorn et al.   Pharmacogenetics and Genomics

The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS

(2009) Guan-Wei Fan et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Inhibition of microsomal triglyceride transfer protein expression and atherogenic risk factor apolipoprotein B100 secretion by tanshinone IIA in HepG2 cells

(2008) Yun-Jeong Kang et al.   PHYTOTHERAPY RESEARCH